InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Metzger Michael A, Chairman & CEO. Insider active across 1 companies, notably Syndax Pharmaceuticals Inc. Aggregated, 12 filings have been logged. The latest transaction was disclosed on 16 December 2021 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations12 total
€128,35422,715 shares@ €5.65060.0072% mcap14.9% of flow
Common Stock
SEC:0001562180-21-007809·
€128,35422,715 shares@ €5.65060.0072% mcap7.4% of flow
Common Stock
SEC:0001562180-21-007809:0·
€13,0162,045 shares@ €6.3650.0007% mcap1.5% of flow
Common Stock
SEC:0001562180-21-007710·
€13,0162,045 shares@ €6.3650.0007% mcap0.8% of flow
Common Stock
SEC:0001562180-21-007710:0·
€277,19344,704 shares@ €6.20060.015% mcap32.1% of flow
Common Stock
SEC:0001562180-21-006652·
€277,19344,704 shares@ €6.20060.015% mcap16.0% of flow
Common Stock
SEC:0001562180-21-006652:0·
€150,42324,437 shares@ €6.15550.0084% mcap17.4% of flow
Common Stock
SEC:0001562180-21-006136·
€150,42324,437 shares@ €6.15550.0084% mcap8.7% of flow
Common Stock
SEC:0001562180-21-006136:0·
€193,07131,455 shares@ €6.1380.011% mcap22.4% of flow
Common Stock
SEC:0001562180-21-006060·
€193,07131,455 shares@ €6.1380.011% mcap11.2% of flow
Common Stock
SEC:0001562180-21-006060:0·
€101,49716,651 shares@ €6.09550.0057% mcap11.8% of flow
Common Stock
SEC:0001562180-21-005948·
€101,49716,651 shares@ €6.09550.0057% mcap5.9% of flow
Common Stock
SEC:0001562180-21-005948:0·
12 of 12 declarations
About Metzger Michael A
Michael A. Metzger serves as President and COO at Syndax Pharmaceuticals Inc. In this role, he is responsible for the overall strategy and operational direction of the company. With extensive experience in the pharmaceutical sector, he oversees daily operations and guides the company toward sustainable growth and increased profitability.
